| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oramed Pharmaceuticals Inc. (ORMP) has 9 insiders with recent SEC Form 4 filings, including 13 buys and 7 sells. ORMP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.45M | $6.61M | - | |
| CFO | 649.3K | $2.96M | - | |
| Dir | 163.1K | $744.8K | - | |
| Dir | 134.5K | $614.3K | - | |
| Dir | 119.7K | $546.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2016 | Kidron Nadav67 | President And CEO | Buy | 1,000 | $6.95 | $6,953.00 | - | |
| Mar 10, 2016 | Jacob Harold | Director | Sell | 8,500 | $6.45 | $54,842.00 | -34.1% | |
| Dec 30, 2015 | Kidron Miriam | Chief Technology Officer | Sell | 50,000 | $8.90 | $444,799.70 | -9.3% | |
| Dec 9, 2015 | Berelowitz Michael | Director | Sell | 700 | $9.44 | $6,608.00 | -3.0% | |
| Dec 8, 2015 | Berelowitz Michael | Director | Sell | 1,300 | $8.70 | $11,310.00 | -2.6% | |
| May 12, 2015 | Kidron Nadav67 | President And CEO | Buy | 600 | $6.60 | $3,962.00 | - | |
| Mar 19, 2015 | Kidron Nadav67 | President And CEO | Buy | 2,600 | $3.88 | $10,082.00 | - |